Breakfast News: A Conversation With Ionis CEO
Ionis Pharmaceuticals CEO on a major profitability milestone, breakthrough medicines and more.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Key indicators show strong growth as Pakistan moves towards economic transformation: Ahsan Iqbal
Federal Minister for Planning, Development and Special Initiatives Ahsan Iqbal said that Pakistan’s economy had entered a phase of greater stability, but stressed that the next priority was to…
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket?
Key PointsInvesco Nasdaq Biotechnology ETF has a significantly lower expense ratio and double the dividend yield of VanEck Biotech ETF.
What Warren Buffett and Tony Elumelu’s Legendary Lives Tell Us
VIEW POINT In a deeply personal and reflective letter to shareholders at the end of 2025, America’s billionaire investor, Warren Buffett, reminded the world that while money matters, the highest
- Warren Buffett donates $1.35 billion to four family foundations
- Buffett's philanthropy has transferred over $200 billion
- Tony Elumelu supports African entrepreneurship through foundations
Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter.
This sale was non-discretionary, executed to cover tax withholding from RSU vesting.
Why Opera Stock Sank This Week
Key PointsOpera's adjusted earnings met Wall Street's target in Q2, and sales came in above expectations.